Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 4 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Kymera Therapeutics INC paid sponsored hires in similar roles1 certified filing for “Associate Scientist, Discovery Biology” (Biochemists and Biophysicists) in MA: $126k–$126k, median $126k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 4 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Kymera Therapeutics INC paid sponsored hires in similar roles
- 1 certified filing for “Associate Scientist, Discovery Biology” (Biochemists and Biophysicists) in MA: $126k–$126k, median $126k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Who we are:
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn .
How we work:
• PIONEER : We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
• COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine.
• BELONG : We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard.
How you’ll make an impact:
• Serve as the study level Clinical Scientist in immunology, with a focus on dermatologic indications, actively participating in study team meetings, vendor meetings, and data/safety monitoring committees.
• Support the design of clinical trial protocols and amendments, ensuring scientific integrity and alignment with regulatory standards. Collaborate with Translational Medicine to integrate biomarker testing and with Clinical Pharmacology to integrate pharmacokinetic sampling into trial protocols.
• Prepare and review essential documents such as medical monitoring plans, statistical analysis plans, informed consent forms, case report forms and clinical study reports.
• Support study execution as scientific subject matter expert.
• Conduct clinical data reviews, including safety monitoring activities, to ensure patient safety and data accuracy and integrity.
• Data review, cleaning, and monitoring utilizing data visualization tools, and protocol deviations review to analyze trends, identify risks and implement mitigation strategies.
• Support IRB and regulatory submissions and query responses.
• Present data and information to external investigators and internal stakeholders, contributing to meetings with governance bodies and regulatory authorities.
• Work within a matrix environment, collaborating with medical directors, regulatory affairs, translational medicine, clinical operations, data management, biostatistics, and other departments to drive clinical development programs forward.
Skills and experience you’ll bring:
• Bachelor’s or advanced degree (MSc, PharmD, PhD) in Life Sciences or related field and 8+ years in pharmaceutical clinical drug development, with experience in global clinical trials and program execution.
• Experience in immunological diseases with an understanding of disease biology and treatment landscapes; Experience with clinical trials for dermatologic indications and endpoints is a plus.
• In-depth understanding of clinical development processes, regulatory requirements, and guidelines (FDA, EMEA, ICH, GCP).
• Strong critical-thinking, problem-solving abilities and excellent medical writing skills.
• Maintain a patient-centric mentality throughout the drug development process.
Equal Employment Opportunity
Kymera Therapeutics is proud to be an equal opportunity employer, seeking to create a welcoming and diverse environment. All applicants will receive consideration for employment w
Apply on company site ↗